Lokelma

(sodium zirconium cyclosilicate) AstraZeneca

Composition:

• Available in powder for oral suspension with each sachet contains 5 g or 10 g sodium zirconium cyclosilicate

Indication:

• For the treatment of hyperkalaemia in adult patients
  
  Drug information including formulation, indication, administration and/or presentation updated, registered or launched in Hong Kong within one year prior to the date written is regarded as new in The Pace.
  The information in The Pace is provided as a courtesy service to our readers and is intended for medical professional reference only. Please peruse the latest local prescription information prior to prescription.